EyePoint(EYPT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EYPT EyePoint

交易中 02-13 13:53:18 EST

13.09

+0.08

+0.61%

最高13.69	最低12.85	成交量34.73万
今开13.13	昨收13.01	日振幅6.46%
总市值10.84亿	流通市值7.84亿	总股本8,279万
成交额460.53万	换手率0.58%	流通股本5,991万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"EYPT","market":"US","secType":"STK","nameCN":"EyePoint","latestPrice":13.09,"timestamp":1771008789263,"preClose":13.01,"halted":0,"volume":347294,"delay":0,"changeRate":0.006149116064565724,"floatShares":59905600,"shares":82787220,"eps":-2.998437,"marketStatus":"交易中","change":0.08,"latestTime":"02-13 13:53:18 EST","open":13.13,"high":13.69,"low":12.85,"amount":4605279.237122,"amplitude":0.064566,"askPrice":13.09,"askSize":15,"bidPrice":13.07,"bidSize":232,"shortable":3,"etf":0,"ttmEps":-2.998437,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1771016400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":13.01,"preHourTrading":{"tag":"盘前","latestPrice":13.12,"preClose":13.01,"latestTime":"09:29 EST","volume":1238,"amount":16223.77954,"timestamp":1770992999999,"change":0.11,"changeRate":0.008455,"amplitude":0.060723},"postHourTrading":{"tag":"盘后","latestPrice":13.01,"preClose":13.01,"latestTime":"19:35 EST","volume":6484,"amount":84356.1707,"timestamp":1770942924364,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.554858,"impliedVol":2.3725,"impliedVolPercentile":0.988},"requestUrl":"/m/hq/s/EYPT/tweets","defaultTab":"tweets","newsList":[{"id":"2603574124","title":"Eyepoint, Inc.盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603574124","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603574124?lang=zh_cn&edition=full","pubTime":"2026-01-13 01:42","pubTimestamp":1768239765,"startTime":"0","endTime":"0","summary":"北京时间2026年01月13日01时42分，Eyepoint, Inc.股票出现异动，股价快速跳水5.15%。Eyepoint, Inc.股票所在的生物技术行业中，整体跌幅为1.58%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Beam Therapeutics Inc.、Forte Biosciences, Inc.涨幅较大，Jaguar Health, Inc.、Osr Holdings, Inc.、Genprex, Inc.较为活跃，换手率分别为645.22%、132.61%、101.83%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Jasper Therapeutics Inc C/Wts 24/09/2026 、Mindwalk Holdings Corp.，振幅分别为32.48%、31.29%、31.25%。Eyepoint, Inc.公司简介：EyePoint Inc专注于开发和商业化用于治疗严重视网膜疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113014245953c7428&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113014245953c7428&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1951200564.SGD","LU0390134368.USD","LU1316542783.SGD","LU1951198990.SGD","BK4612","LU0889565916.HKD","LU0056508442.USD","LU0109394709.USD","BK4585","LU0320765992.SGD","IE00BMPRXR70.SGD","BK4141","LU0109392836.USD","LU2264538146.SGD","BK4575","LU0823421416.USD","LU0823434740.USD","LU2458330243.SGD","LU2355687059.USD","BK4543","IE00B5949003.HKD","BK4532","LU0642271901.SGD","BK4512","BK4534","BK4605","LU0081259029.USD","BK4529","LU0127658192.USD","LU0274383776.USD","LU1880398554.USD","LU1923623000.USD","LU0198837287.USD","LU0889565833.HKD","LU1064131342.USD","LU1880398471.USD","LU0082616367.USD","LU1989764664.SGD","LU2098885051.SGD","LU2089985449.USD","LU1242518857.USD","BK4007","BK4614","LU0823421333.USD","LU1988902786.USD","EYPT","LU2931357623.SGD","LU2360106780.USD","LU0719512351.SGD","LU1303367103.USD","IE0004445239.USD","LU0823434583.USD","BK4554","LU0979878070.USD","IE00BMPRXN33.USD","LU1861559042.SGD","LU1861558580.USD","BK4588","LU2054465674.USD","LU1242518931.SGD","BK4566","LU1852331112.SGD","LU2458330169.SGD","LU1803068979.SGD","LU2250418816.HKD","BK4573","IE0009356076.USD"],"gpt_icon":0},{"id":"2602308538","title":"Eyepoint, Inc.盘中异动 下午盘股价大跌5.04%报16.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602308538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602308538?lang=zh_cn&edition=full","pubTime":"2026-01-10 03:00","pubTimestamp":1767985243,"startTime":"0","endTime":"0","summary":"北京时间2026年01月10日03时00分，Eyepoint, Inc.股票出现异动，股价急速下跌5.04%。截至发稿，该股报16.22美元/股，成交量48.1253万股，换手率0.58%，振幅6.70%。Eyepoint, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Eyepoint, Inc.公司简介：EyePoint Inc专注于开发和商业化用于治疗严重视网膜疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011003004397a157fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011003004397a157fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1880398471.USD","IE00BMPRXN33.USD","LU0823421416.USD","LU1316542783.SGD","LU2458330243.SGD","LU0889565833.HKD","LU1861558580.USD","LU1852331112.SGD","LU2250418816.HKD","LU2264538146.SGD","LU0979878070.USD","LU1803068979.SGD","LU0642271901.SGD","BK4529","BK4554","BK4573","LU0109394709.USD","BK4566","LU0719512351.SGD","LU0274383776.USD","LU0390134368.USD","LU0823434583.USD","LU1951200564.SGD","BK4141","LU1989764664.SGD","LU0320765992.SGD","LU0823421333.USD","LU2054465674.USD","LU0081259029.USD","LU0127658192.USD","LU1923623000.USD","BK4585","BK4605","LU2098885051.SGD","IE0009356076.USD","BK4534","LU1303367103.USD","LU0823434740.USD","LU1988902786.USD","LU2355687059.USD","IE00B5949003.HKD","LU1951198990.SGD","IE0004445239.USD","IE00BMPRXR70.SGD","LU1861559042.SGD","BK4588","LU0056508442.USD","LU0889565916.HKD","LU0082616367.USD","LU2458330169.SGD","LU2931357623.SGD","LU1242518857.USD","BK4575","LU2089985449.USD","LU0198837287.USD","LU1242518931.SGD","LU0109392836.USD","BK4512","LU1064131342.USD","LU1880398554.USD","LU2360106780.USD","BK4543","BK4612","EYPT","BK4007","BK4614","BK4532"],"gpt_icon":0},{"id":"1150797872","title":"EyePoint获得独立数据安全监测委员会对Duravyu™在湿性年龄相关性黄斑变性关键三期临床试验的积极推荐","url":"https://stock-news.laohu8.com/highlight/detail?id=1150797872","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150797872?lang=zh_cn&edition=full","pubTime":"2025-11-19 20:02","pubTimestamp":1763553741,"startTime":"0","endTime":"0","summary":"EyePoint获得独立数据安全监测委员会对Duravyu™在湿性年龄相关性黄斑变性关键三期临床试验的积极推荐","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU0109394709.USD","EYPT","BK4585","LU0889565916.HKD","BK4588","BK4007"],"gpt_icon":0},{"id":"1153527707","title":"EyePoint制药或与Cantor Fitzgerald联合提供及出售高达2亿美元的普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1153527707","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153527707?lang=zh_cn&edition=full","pubTime":"2025-11-07 07:23","pubTimestamp":1762471392,"startTime":"0","endTime":"0","summary":"EyePoint制药或与Cantor Fitzgerald联合提供及出售高达2亿美元的普通股","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0889565916.HKD","EYPT","LU0320765992.SGD","BK4007","BK4585","LU0109394709.USD"],"gpt_icon":0},{"id":"1150470228","title":"EyePoint 2025财年Q3业绩会总结及问答精华：DuraVu临床进展与市场前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1150470228","media":"业绩会速递","labels":["earningsCall"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150470228?lang=zh_cn&edition=full","pubTime":"2025-11-06 06:11","pubTimestamp":1762380701,"startTime":"0","endTime":"0","summary":"我们相信DuraVu在市场上将有很好的定位。对照组将使用标签上的aflibercept，DuraVu每六个月给药一次。DuraVu的活性成分vorolanib通过阻断JAK1受体抑制IL-6信号传导，可能显著改善治疗效果。EyePoint Pharmaceuticals在2025年第三季度展示了其主要候选药物DuraVu的显著临床进展，特别是在湿性AMD和DME领域。尽管财务业绩有所下降，但公司强大的现金储备和持续的临床试验进展使其在2026年有望取得重要里程碑。管理层对DuraVu的市场潜力充满信心，预计其多机制作用将显著改善治疗效果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"earningsCall","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EYPT"],"gpt_icon":0},{"id":"1139866701","title":"EyePoint Pharmaceuticals Inc宣布启动Duravy治疗糖尿病性黄斑水肿的3期临床试验项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1139866701","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139866701?lang=zh_cn&edition=full","pubTime":"2025-10-15 04:02","pubTimestamp":1760472171,"startTime":"0","endTime":"0","summary":"EyePoint Pharmaceuticals Inc宣布启动Duravy治疗糖尿病性黄斑水肿的3期临床试验项目。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU0109394709.USD","EYPT","LU0889565916.HKD","BK4585","BK4588","LU0320765992.SGD"],"gpt_icon":0},{"id":"2574818970","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 股价大涨5.21%报13.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574818970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574818970?lang=zh_cn&edition=full","pubTime":"2025-10-08 23:14","pubTimestamp":1759936452,"startTime":"0","endTime":"0","summary":"北京时间2025年10月08日23时14分，Eyepoint Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.21%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。其相关个股中，Xenetic Biosciences, Inc.、Cingulate Inc C/Wts 10/12/2026 、Protagenic Therapeutics Inc C/Wts 26/04/2026 涨幅较大，Xenetic Biosciences, Inc.、Acurx Pharmaceuticals, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为2631.72%、1258.79%、830.71%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、Xenetic Biosciences, Inc.、Transcode Therapeutics, Inc.，振幅分别为107.47%、86.01%、63.90%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008231412a6b0e345&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008231412a6b0e345&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EYPT","BK4585","LU0320765992.SGD","LU0109394709.USD","BK4588","LU0889565916.HKD","BK4007"],"gpt_icon":0},{"id":"2565516478","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.09%报12.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565516478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565516478?lang=zh_cn&edition=full","pubTime":"2025-09-05 22:09","pubTimestamp":1757081382,"startTime":"0","endTime":"0","summary":"北京时间2025年09月05日22时09分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.09%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。其相关个股中，Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Fortress Biotech, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026涨幅较大，Cero Therapeutics Holdings, Inc.、Novabay Pharmaceuticals, Inc.、Palisade Bio, Inc.较为活跃，换手率分别为338.85%、82.56%、44.48%，振幅较大的相关个股有Propanc Biopharma, Inc.、Humacyte Inc C/Wts 27/08/2026 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com，振幅分别为27.78%、26.94%、23.89%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250905220942977a6c45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250905220942977a6c45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","PT","BK4588","LU0889565916.HKD","BK4166","BK4585","EYPT","BK4007","LU0109394709.USD"],"gpt_icon":0},{"id":"2518289200","title":"Eyepoint Pharmaceuticals, Inc.2024财年实现净利润-1.31亿美元，同比减少85.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518289200","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518289200?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:00","pubTimestamp":1741536045,"startTime":"0","endTime":"0","summary":"3月10日，Eyepoint Pharmaceuticals, Inc.公布财报，公告显示公司2024财年净利润为-1.31亿美元，同比减少85.03%；其中营业收入为43.27百万美元，同比减少5.98%，每股基本收益为-2.32美元。从资产负债表来看，Eyepoint Pharmaceuticals, Inc.总负债81.96百万美元，其中短期债务1.25百万美元，资产负债比为0.06，流动比率为0.08。机构评级：截至2025年3月10日，当前有12家机构对Eyepoint Pharmaceuticals, Inc.目标价做出预测，其中目标均价为33.17美元，其中最低目标价为18.00美元，最高目标价为68.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000101a26897f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000101a26897f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EYPT"],"gpt_icon":0},{"id":"2517215166","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 股价大跌5.02%报6.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517215166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517215166?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:30","pubTimestamp":1741271457,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时30分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.02%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Plus Therapeutics, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Exicure, Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为904.80%、95.93%、44.61%，振幅较大的相关个股有Mbx Biosciences, Inc.、Tiziana Life Sciences Ltd、Neuphoria Therapeutics Inc.，振幅分别为8.18%、8.09%、5.97%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223057abeb7730&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223057abeb7730&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","EYPT","LU0109394709.USD","LU0320765992.SGD","BK4007","BK4585","BK4588"],"gpt_icon":0},{"id":"2517488839","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 早盘大幅上涨6.09%报6.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517488839","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517488839?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:40","pubTimestamp":1741185615,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时40分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价大幅拉升6.09%。截至发稿，该股报6.45美元/股，成交量2.5492万股，换手率0.04%，振幅4.49%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc C/Wts 16/07/2026 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为408.84%、265.02%、198.88%，振幅较大的相关个股有Aditxt, Inc.、Silexion Therapeutics Corp、Exicure, Inc.，振幅分别为23.90%、20.71%、18.00%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224015a260ca86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224015a260ca86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","EYPT","BK4588","BK4007","BK4585"],"gpt_icon":0},{"id":"2516659415","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 快速下跌5.10%报5.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516659415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516659415?lang=zh_cn&edition=full","pubTime":"2025-03-04 01:27","pubTimestamp":1741022862,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日01时27分，Eyepoint Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.10%。截至发稿，该股报5.95美元/股，成交量28.3541万股，换手率0.42%，振幅9.73%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Bioxcel Therapeutics, Inc.、Alto Neuroscience, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为4191.65%、177.48%、156.72%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304012743abe668bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304012743abe668bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EYPT","BK4585","LU0320765992.SGD","LU0889565916.HKD","BK4007","LU0109394709.USD","BK4588"],"gpt_icon":0},{"id":"2514338749","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 临近午盘股价大涨5.08%报6.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514338749","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514338749?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:33","pubTimestamp":1740674008,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时33分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.08%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Alpha Tau Medical Ltd C/Wts 、Heron Therapeutics, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1668.94%、270.98%、113.20%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Quoin Pharmaceuticals Ltd、Pds Biotechnology Corporation，振幅分别为86.14%、47.79%、45.45%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228003328abdf8be1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228003328abdf8be1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","BK4585","BK4588","EYPT","LU0889565916.HKD","BK4007","LU0320765992.SGD"],"gpt_icon":0},{"id":"2512655411","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 大幅上涨5.08%报6.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512655411","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512655411?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:32","pubTimestamp":1739889128,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时32分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.08%。截至发稿，该股报6.83美元/股，成交量1.8195万股，换手率0.03%，振幅2.15%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为276.09%、91.01%、60.62%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Allakos Inc.、Virpax Pharmaceuticals, Inc.，振幅分别为8.57%、8.35%、6.13%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223208a24aacba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223208a24aacba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU0889565916.HKD","EYPT","BK4585","BK4007","LU0320765992.SGD","BK4588"],"gpt_icon":0},{"id":"2511869691","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511869691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511869691?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:48","pubTimestamp":1739544539,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时48分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.23%。截至发稿，该股报6.64美元/股，成交量3.3712万股，换手率0.05%，振幅4.28%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1852.91%、485.12%、421.78%，振幅较大的相关个股有Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Klotho Neurosciences, Inc.，振幅分别为66.93%、32.93%、32.49%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422485998858e15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422485998858e15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU0320765992.SGD","LU0109394709.USD","BK4588","BK4585","LU0889565916.HKD","EYPT"],"gpt_icon":0},{"id":"2510864388","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 早盘快速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510864388","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510864388?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:52","pubTimestamp":1739202744,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时52分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.00%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Biodexa Pharmaceuticals Plc、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2670.33%、1536.97%、1006.83%，振幅较大的相关个股有Abpro Holdings Inc C/Wts 12/11/2029 、Ocean Biomedical, Inc.、Biodexa Pharmaceuticals Plc，振幅分别为87.80%、69.83%、66.09%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021023522498808885&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021023522498808885&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU0109394709.USD","EYPT","LU0889565916.HKD","BK4585","BK4588","LU0320765992.SGD"],"gpt_icon":0},{"id":"2509282518","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 股价大跌13.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509282518","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509282518?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:30","pubTimestamp":1738765804,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时30分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价大幅下跌13.12%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Oragenics Inc.、Nanoviricides, Inc.、Cognition Therapeutics, Inc.涨幅较大，Pasithea Therapeutics Corp.、60 Degrees Pharmaceuticals, Inc.、Oragenics Inc.较为活跃，换手率分别为1970.72%、561.06%、552.84%，振幅较大的相关个股有Kairos Pharma, Ltd.、Can Fite Biopharma Ltd、Actinium Pharmaceuticals, Inc. ，振幅分别为5.75%、4.32%、2.56%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223005a23a79db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223005a23a79db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU0889565916.HKD","BK4585","BK4588","LU0320765992.SGD","EYPT","LU0109394709.USD"],"gpt_icon":0},{"id":"2509546126","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 临近午盘快速上涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509546126","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509546126?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:49","pubTimestamp":1738687763,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日00时49分，Eyepoint Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.16%。截至发稿，该股报7.54美元/股，成交量11.9164万股，换手率0.17%，振幅5.02%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.48%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Azitra Inc、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1678.40%、935.96%、549.21%，振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Cingulate Inc C/Wts 10/12/2026 ，振幅分别为72.82%、49.88%、47.32%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502050049239617ede7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502050049239617ede7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","BK4588","EYPT","BK4585","LU0109394709.USD","BK4007","LU0320765992.SGD"],"gpt_icon":0},{"id":"2507702586","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 股价大涨5.17%报8.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507702586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507702586?lang=zh_cn&edition=full","pubTime":"2025-01-31 04:23","pubTimestamp":1738268607,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日04时23分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.17%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Dominari Holdings Inc.涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1824.88%、333.27%、255.30%，振幅较大的相关个股有Dominari Holdings Inc.、Cero Therapeutics Holdings, Inc.、Kazia Therapeutics Limited，振幅分别为70.55%、65.98%、65.94%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013104232796146408&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013104232796146408&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU0889565916.HKD","BK4585","LU0109394709.USD","BK4007","BK4588","EYPT"],"gpt_icon":0},{"id":"2506258302","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.16%报8.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506258302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506258302?lang=zh_cn&edition=full","pubTime":"2025-01-28 02:21","pubTimestamp":1738002095,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日02时21分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.16%。截至发稿，该股报8.09美元/股，成交量13.7217万股，换手率0.20%，振幅6.62%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Akero Therapeutics, Inc.、Dogwood Therapeutics, Inc.、89Bio, Inc.涨幅较大，Onconetix, Inc.、Dogwood Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为2148.53%、994.21%、256.17%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为108.60%、99.77%、65.16%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128022135a2319877&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128022135a2319877&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU0320765992.SGD","EYPT","LU0109394709.USD","BK4585","LU0889565916.HKD","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.eyepointpharma.com","stockEarnings":[{"period":"1week","weight":0.022},{"period":"1month","weight":-0.1833},{"period":"3month","weight":0.1235},{"period":"6month","weight":0.1731},{"period":"1year","weight":1.0488},{"period":"ytd","weight":-0.2879}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":-0.018},{"period":"3month","weight":0.0139},{"period":"6month","weight":0.0588},{"period":"1year","weight":0.1291},{"period":"ytd","weight":-0.001}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"EyePoint, Inc.于2008年3月19日在特拉华州注册成立，是一家临床阶段的生物制药公司，致力于开发和商业化创新疗法，以帮助改善患有严重视网膜疾病的患者的生活。公司采用其专有的生物可降解Durasert E技术进行持续的眼内药物输送，从而解决了频繁玻璃体内注射带来的难题。其主要候选产品DURAVYU是一种用于治疗血管内皮生长因子介导的视网膜疾病的在研疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.047593},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.01064},{"month":3,"riseRate":0.380952,"avgChangeRate":-0.000657},{"month":4,"riseRate":0.52381,"avgChangeRate":0.155574},{"month":5,"riseRate":0.380952,"avgChangeRate":0.00075},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.02035},{"month":7,"riseRate":0.619048,"avgChangeRate":0.044584},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.024706},{"month":9,"riseRate":0.380952,"avgChangeRate":0.007468},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.047614},{"month":11,"riseRate":0.47619,"avgChangeRate":-0.049639},{"month":12,"riseRate":0.380952,"avgChangeRate":0.116746}],"exchange":"NASDAQ","name":"EyePoint","nameEN":"EyePoint"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"EyePoint(EYPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供EyePoint(EYPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"EyePoint,EYPT,EyePoint股票,EyePoint股票老虎,EyePoint股票老虎国际,EyePoint行情,EyePoint股票行情,EyePoint股价,EyePoint股市,EyePoint股票价格,EyePoint股票交易,EyePoint股票购买,EyePoint股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"EyePoint(EYPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供EyePoint(EYPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}